Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis
Edouard Alphandéry. Int. J. Mol. Sci. 2022, 23(3).
Preclinical proof of concepts of the treatment developed by AlphaOnco have been developped pre-clinicaly and tested on different solid and organ-confined tumors.
Edouard Alphandéry ranked in the Stanford/Elsevier Top 2% Scientists List for the years 2020, 2021, 2022, 2023, 2024 and 2025.